Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Frontiers in Immunology|January 11, 2014
Nuclear Factor κB is Required for Tumor Growth Inhibition Mediated by Enavatuzumab (PDL192), a Humanized Monoclonal Antibody to TweakRJames W Purcell, Han K Kim, Sonia G Tanlimco, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2013
Safety, tolerability, pharmacokinetics, and antiviral activity of GSK2336805, an inhibitor of hepatitis C virus (HCV) NS5A, in healthy subjects and subjects chronically infected with HCV genotype 1D A Wilfret, J Walker, K K Adkison, et al.
Urology|July 1, 1983
Cryosurgery in prostatic cancer: elimination of local lesionW W Bonney, B Fallon, W L Gerber, et al.
Urology|January 1, 1982
Cryosurgery in prostatic cancer: survivalW W Bonney, B Fallon, W L Gerber, et al.
Journal of Cancer Research and Clinical Oncology|October 18, 2012
Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAbDebra T Chao, Mian Su, Sonia Tanlimco, et al.
Frontiers in Physiology|April 10, 2023
Concurrent validity of machine learning-classified functional upper extremity use from accelerometry in chronic strokeShashwati Geed, Megan L Grainger, Abigail Mitchell, et al.
Mabs|July 21, 2020
COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumorsAnand Panchal, Pui Seto, Russell Wall, et al.
Plos One|November 7, 2014
Predictive gene signature of response to the anti-TweakR mAb PDL192 in patient-derived breast cancer xenograftsLudmilla de Plater, Anne Vincent-Salomon, Frédérique Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanismsPatricia A Culp, Donghee Choi, Yongke Zhang, et al.
Molecular Cancer Therapeutics|October 22, 2017
Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid TumorsElaine T Lam, S Gail Eckhardt, Wells Messersmith, et al.
Pageof 19